Literature DB >> 34260243

An Integrated Approach for Discovering Noncanonical MHC-I Peptides Encoded by Small Open Reading Frames.

Lei Chen1, Yuanliang Zhang2, Ying Yang2, Yang Yang2, Huihui Li3, Xuan Dong4, Hongwei Wang3, Zhi Xie3, Qian Zhao2.   

Abstract

MHC-I peptides are a group of important immunopeptides presented by major histocompatibility complex (MHC) on the cell surface for immune recognition. The majority of reported MHC-I peptides are derived from protein coding sequences, and noncanonical peptides translated from small open reading frames (sORF) are largely unknown due to the lack of accurate and sensitive detection methods. Herein we report an efficient approach that implements complementary bioinformatic strategies to improve the identification of noncanonical MHC-I peptides. In a database search strategy, noncanonical immunopeptides mapping was optimized by combining three complementary pipelines to construct predicted sORF databases from Ribo-seq data. In a de novo peptide sequencing strategy, MS data search results were filtered against sORF databases to pin down additional noncanonical immunopeptides. In total, 308 noncanonical immunopeptides were identified from two tumor cell lines with selected ones vigorously validated. Our approach is a handy solution to identify noncanonical MHC peptides with Ribo-seq and MS data. Meanwhile, the novel noncanonical immunopeptides identified with this method could shed insights on fundamental immunology as well as cancer immunotherapies.

Entities:  

Keywords:  MHC-I peptides; Ribo-seq; database search; de novo sequencing; small open reading frames

Mesh:

Substances:

Year:  2021        PMID: 34260243     DOI: 10.1021/jasms.1c00076

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  1 in total

1.  A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources.

Authors:  Haitao Xiang; Le Zhang; Fanyu Bu; Xiangyu Guan; Lei Chen; Haibo Zhang; Yuntong Zhao; Huanyi Chen; Weicong Zhang; Yijian Li; Leo Jingyu Lee; Zhanlong Mei; Yuan Rao; Ying Gu; Yong Hou; Feng Mu; Xuan Dong
Journal:  Cancers (Basel)       Date:  2022-06-19       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.